glp-1 calibrate Microdosing for Perimenopause and Menopause: A Hormone-Aware Metabolic Framework Not all GLP-1 care is

Sao Paulo Med J 139(4):398404

Ozempic lawsuits are pending across the country, with over 1,200 currently consolidated into an MDL out of the Eastern District of Pennsylvania

Unlike traditional one-size-fits-all therapies, personalized nanomedicine can adapt to disease heterogeneity, patient-specific pathology, and pharmacogenomic profiles, thereby improving long-term efficacy and minimizing adverse effects

doi: 10.1038/s41443-025-01061-2

Medicaid coverage for weight loss medications varies by state

In a clinical trial, people receiving the treatment are able to adhere to the prescribed regimen through support from study staff and incentives for participation, whereas in a real-world setting people may experience side effects or lose insurance coverage and stop taking their medications, Stokes says